References
- A. Rajendarn and S. K. Basu, Crystal modification of dipyridamole using different solvents and crystallization conditions, Int. J. Pharm. 321 (2006) 27-34; DOI: 10.1016/J.IJPHARM.2006.04.021.
- N. Blagden, M. de Matas, P. T. Gavan and P. York, Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates, Adv. Drug Del. Rev. 59 (2007) 617-630; DOI: 10.1016/J.ADDR.2007.05.011.
- S. R. Byrn, R. R. Pfeiffer, G. Stephenson, D. J. W. Grant and W. B. Gleason, Solid state pharmaceutical chemistry, Chem. Mater. 6 (1994) 1148; DOI: 10.1021/cm00044a013.
- M. El-Baldry, G. Fetih and M. Fathy, Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG 4000, Saudi Pharm. J. 17 (2009) 219-229; DOI: 10.1016/J.JSPS.2009.08.006.
- M. Fernandez, I. C. Rodriguez and A. Crezo, Characterization of solid dispersions of piroxicam/polyethylene glycol 4000, Int. J. Pharm. 84 (1992) 197-202; DOI: 10.1016/0378-5173(92)90060-F.
- D. Horter and J. B. Dressman, Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract, Adv. Drug Del Rev. 25 (1997) 3-14; DOI: 10.1016/S0169-409X (00) 00130-7.
- P. B. Myrdal and M. J. Jozwiakowski, Water-Insoluble Drug Formulation, in Alteration of the Solid State of the Drug Substances: Polymorphs, Solvates, and Amorphous Forms, 2nd ed. (Ed. R. Lin), AustarPharma, Edison (NJ), 2008.
- M. C. Martinez-Oharriz, C. Martýn, M. M. Goni, C. Rodrýguez-Espinosa, A. Zornoza and M. C. Tros-Ilarduya, Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal, Eur. J. Pharm. Sci. 8 (1999) 127-132; DOI: 10.1016/S0928-0987(99)00006-8.
- M. Mihalić, H. Hofman, J. Kuftinec, B. Krile, M. Zinic, F. Kajfez and N. Blazevic, Physicochemical and analytical characteristics of piroxicam, Acta Pharm. Jugosl. 32 (1982) 13-20.
- K. Srinivasan, K. Sankaranarayanan, S. Thangavelu and P. Ramasamy, Influence of organic solvents on the habit of NMBA (4-nitro-4'-methyl benzylidene aniline) crystals, J. Cryst. Grow. 212 (2000) 246-54; DOI: 10.1016/S0022-0248(00)00300-6.
- V. Tantishaiyakul, N. Kaewnopparat and S. Ingkatawornwong, Properties of solid dispersion of piroxicam in polyvinylpyrrodine, Int. J. Pharm. Sci. 181 (1999) 143-51; DOI: 10.1016/S0378-5173(96)04687-X.
- S. Verheyen, N. Blaton, R. Kinget and G. Van den Mooter, Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions, Int. J. Pharm. 249 (2002) 45-58; DOI: 10.1016/S0378-5173(02)00532-X.
- F. Vrecer and S. Srcic, Investigation of piroxicam polymorphism, Int. J. Pharm. 68 (1990) 35-41; DOI: 10.1016/S0378-5173(03)00057-7.
- F. Vrečer, M. Vrbinc and A. Meden, Characterisation of piroxicam crystal modifications, Int. J. Pharm. 256 (2003) 3-15; DOI: 10.1016/S0378-5173(03)00057-7.
- United States Pharmacopoeia 24/National Formulary 19, USP Pharmacopoeial Convention, Rockville (MD) 2000.